Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Molecular therapy for rhabdomyosarcoma
Raushan T. Kurmasheva
, Hajime Hosoi
, Ken Kikuchi
, Peter J. Houghton
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular therapy for rhabdomyosarcoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Rhabdomyosarcoma
100%
Neoplasm
28%
Sarcoma
21%
Therapeutic Procedure
21%
Metastatic Carcinoma
14%
Toxicity
14%
Aberration
14%
Development
14%
Cytotoxic Agent
14%
Gene
14%
Child
14%
Childhood
14%
Imprinting (Psychology)
14%
Histology
7%
Combination Therapy
7%
Diagnosis
7%
Transactivation
7%
Radiosensitivity
7%
DNA Binding
7%
Chronic Myelogenous Leukemia
7%
Differential Diagnosis
7%
Childhood Cancer
7%
Camptothecin
7%
Chemosensitivity
7%
Imatinib
7%
Heterozygosity
7%
Gene Fusion
7%
Muscle Development
7%
Chromosome Translocation
7%
Molecularly Targeted Therapy
7%
Cytotoxic Chemotherapy
7%
Topoisomerase
7%
Gastrointestinal Stromal Tumor
7%
Embryonal Rhabdomyosarcoma
7%
Comprehension
7%
Nursing and Health Professions
Rhabdomyosarcoma
100%
Neoplasm
28%
Sarcoma
21%
Toxicity
14%
Classification
14%
Prognosis
14%
Metastasis
14%
Patient
14%
Cytotoxic Agent
14%
Diagnosis
7%
Combination Therapy
7%
Differential Diagnosis
7%
Chronic Myeloid Leukemia
7%
Histology
7%
Molecular Therapy
7%
Childhood Cancer
7%
Electric Potential
7%
Molecularly Targeted Therapy
7%
Dose
7%
Chromosome Translocation
7%
Radiosensitivity
7%
Embryonal Rhabdomyosarcoma
7%
Camptothecin
7%
Imatinib
7%
DNA Topoisomerase
7%
Gastrointestinal Stromal Tumor
7%
Biochemistry, Genetics and Molecular Biology
Nested Gene
14%
Development
14%
Classification
14%
Genetics
14%
Childhood
14%
Imprinting (Psychology)
14%
Electric Potential
7%
DNA-binding Domain
7%
Transactivation
7%
Chemosensitivity
7%
Topoisomerase
7%
Gene Mutation
7%
Loss of Heterozygosity
7%
Myogenesis
7%
Radiosensitivity
7%
Gene Fusion
7%
Chromosomal Translocation
7%
PAX3
7%
PAX7
7%
Comprehension
7%
Dose
7%
Pediatrics
7%
Neuroscience
Gene
14%
Histology
7%
Transactivation
7%
Differential Diagnosis
7%
Topoisomerase
7%
Imatinib
7%
Chromosome Translocation
7%
Camptothecin
7%
PAX3
7%
PAX7
7%
Gene Fusion
7%
Molecular Therapy
7%
Pediatrics
7%